Available 24/7 for Urgent On-Site or Virtual Consulting
FDA’s Warning Letter to Novo Nordisk highlights growing FDA focus on pharmacovigilance, adverse event reporting, postmarket surveillance, and enterprise-wide quality systems beyond traditional GMP inspections.
As the regulatory landscape for animal health aligns with human food standards, navigating a pet food FDA inspection has become a high-stakes technical challenge. This 2026 guide explores what investigators prioritize—from FSMA-mandated preventive controls to Salmonella management and supply chain transparency. Learn the strategic steps required to maintain a state of perpetual audit readiness.
Your trusted partner for FDA compliance and inspection readiness. With former ex-FDA’ers on our team, we provide the expertise and confidence you need to succeed.